First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Acupuncture Department, Tianjin, China.
National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
BMJ Open. 2021 Dec 10;11(12):e048686. doi: 10.1136/bmjopen-2021-048686.
Acupuncture is widely used on the rehabilitation of stroke survivors, including hemiplegia, constipation, emotional disorders and so on. Although the effectiveness of manual acupuncture therapy on post-stroke depression (PSD) has been confirmed by multiple randomised controlled trials, there were few meta-analyses focused on the connection between different techniques, durations or other detailed operations of manual acupuncture and their effectiveness of improving the depression severity and quality of life for patients with PSD.
A systematic search will be performed on English databases (PubMed, the Cochrane Library, Medline and Embase), Chinese databases (China National Knowledge Infrastructure, WanFang Data, VIP and Chinese biomedical databases) and Japanese databases (Japan Science and Technology Agency and CiNii). The retrieval time limit will be from the establishment of the database to November 2020. Two researchers will independently screen the literature works, extract data and evaluate the quality of the included studies. Meta-analysis will be conducted by using STATA V.14.0 and Review Manager V.5.3.
The results of this meta-analysis will be disseminated through publication in peer-reviewed journals or conference presentations. The data used in this meta-analysis will not contain individual patient data; therefore, ethical approval is not required.
CRD42020222825.
针刺疗法广泛应用于脑卒中患者的康复治疗,包括偏瘫、便秘、情绪障碍等。虽然多项随机对照试验已经证实了手针疗法对脑卒中后抑郁(PSD)的有效性,但很少有荟萃分析专门关注手针不同技术、持续时间或其他详细操作与改善 PSD 患者抑郁严重程度和生活质量之间的关系。
将在英文数据库(PubMed、Cochrane 图书馆、Medline 和 Embase)、中文数据库(中国知网、万方数据、维普和中国生物医学文献数据库)和日文数据库(日本科学技术振兴机构和 CiNii)中进行系统检索。检索时间限定为从数据库建立到 2020 年 11 月。两位研究者将独立筛选文献、提取数据并评估纳入研究的质量。Meta 分析将使用 STATA V.14.0 和 Review Manager V.5.3 进行。
该荟萃分析的结果将通过发表在同行评议期刊或会议报告中传播。本荟萃分析中使用的数据不包含个体患者数据,因此不需要伦理批准。
PROSPERO 注册号:CRD42020222825。